Knockdown of FGF2 reduced tumor cell growth rates without affecting migration ability compared with the scrambled shRNA–transfected control tumor cells (Supplemental Figure 2, C and D, and Figure 2, B and C). The gene discussed is FGF2; the disease is neoplasm.